New research shows that the delicate balance between maximum clinical impact and toxicity may not be quite as fragile as scientists had previously believed. The study, published by Cell Press in the December issue of the journal Cancer Cell, is likely to have a major impact on the future design and implementation of targeted cancer therapies.
When less is more: Brief inhibition of cancer target is effective and less toxic
- 8. 12 2008 (06:00)